| 000 | 01133nam a22003017a 4500 | ||
|---|---|---|---|
| 001 | 05877 | ||
| 003 | HDC | ||
| 007 | cr bn ---aaaaa | ||
| 008 | 210121b20022002xxu||||| |||| 00| 0 eng d | ||
| 020 | _a0824706749 | ||
| 040 | _aHDC | ||
| 100 |
_aDal Monte, Paul R. _eauthor _96168 |
||
| 245 | 0 |
_aBiotechnology-Based Pharmaceuticals _c/ Paul R. Dal Monte, S. Kathy Edmond Rouan, Narendra B. Bam |
|
| 260 |
_aUnited States: _bMarcel Dekker, _c2002 |
||
| 300 |
_a1 online resource (29 pages) _billustrations |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 500 |
_aOriginally from: Modern Pharmaceutics, 2002 _aIncludes bibliographical references |
||
| 650 |
_aBiopharmaceutics _96169 |
||
| 650 |
_aDrug Industry _96170 |
||
| 700 |
_aBam, Narendra B. _ejoint author _96172 |
||
| 700 |
_aRouan, S. Kathy Edmond _ejoint author _96171 |
||
| 856 | _zRequest full-text at [email protected] | ||
| 942 | _2lcc | ||
| 942 | _cCHAP | ||
| 942 | _kEBCH 004188 | ||
| 999 |
_c3201 _d3201 |
||